Skip to main content
Figure 10 | Kinetoplastid Biology and Disease

Figure 10

From: Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis. Institute Pasteur, Paris. 13–15 June, 2006

Figure 10

Response to Immunochemotherapy of CL in Peru. Double-blind randomized placebo-controlled trial of topical Imiquimod plus antimony vs placebo plus antimony. Forty subjects with clinical resistance to antimony received Sb+5 (20 mg/kg/day im or iv) and were randomized to receive either topical imiquimod 5% cream (Aldara; 3 M Pharmaceuticals) or vehicle control every other day for 20 days. With permission from Miranda et al. Clin. Infect. Dis. 2005, 40: 1395.

Back to article page

Kinetoplastid Biology and Disease

ISSN: 1475-9292